In the present study, a co-immunoprecipitation assay showed that ANXA2 interacted with MYC in ESCC cells (Fig. 4a), implying that ANXA2 may co-localize with MYC in the nucleus. This evidence concerns the gene MYC and esophageal squamous cell carcinoma.